Abstract:Background We have reported that the incidence of hyperuricemia of young female systemic lupus erythematosus (SLE) patients was higher than that of healthy young women[1].Whether the estrogen receptor (ER) expressed in renal tubular tissue contributes to it? There are few reports yet. Objectives To investigate the expression of ERs in the renal tubular cells and their relationship with serum uric acid (UA) levels in premenopausal female SLE patients. Methods Eighteen kidney biopsy specimens of premenopausal female SLE patients served as the lupus nephritis group (LN group), and 12 specimens of premenopausal female IgA nephropaty patients served as the IgA group. Serum UA levels and kidney index were collected, and the expression of ERs in the renal tubular epithelial cell of the two groups were determined by immunohistochemistry. According to the percentage of the positive stained cells, the semiquantitative analysis was made. The expressions of ERs, including ERα and ERβ, of the two groups were compared, and the relationship between the expression of ERs and serum UA levels were analyzed with linear regression analysis. Results 1. The mean ages of the LN group and the IgA group were 27.39±8.09 years and 33.08±5.45 years, respectively, with significantly different (t=2.128, p=0.042). There was no renal failure subject in both groups (CRE level above 120μmol/l), and all the SLE patients were at stage of onset. 2. Mean UA level of the LN group was significantly higher than that of the IgA group (t=-3.149, P=0.004), and the CRE level of the two groups were similar (t=-0.109, P=0.914) (table1). 3. In each group, ERβ was well expressed in the tubular epithelial cells, and no in kidney glomeruli. In contrast, ERα was not expresssed in the renal tissues of both groups (figure1). 4. The median score of ERβ expression in the LN group was remarkable lower than that of the IgA group (z=-2.080, P=0.038, table 1). 5.Linear regression analysis indicated that ERβ expression scores of the total 30 patients had significantly negative correlation with serum UA levels (t=-2.141, P= 0.041, table2). Conclusion 1. Low expression of ERβ in renal tubular epithelial cell may contribute to hyperuricemia in premenopausal female SLE patients. 2. ERα showed no expression in LN and IgA nephropaty kidney tissues. References [1] Haijun Liu, Xiaoyan Cai, Lie Dai, et al. Elevated uric acid levels in premenopausal female systemic lupus erythematosus patients: association with potential or existing renal damage. Eur J Inflamm,2018,16:1-6. Disclosure of Interests None declared

Low expression of estrogen receptor β in renal tubular epithelial cells may cause hyperuricemia in premenopausal patients with systemic lupus erythematosus

FRI0226 LOW EXPRESSION OF ESTROGEN RECEPTOR BETA IN RENAL TUBULAR EPITHELIAL CELL MAY CONTRIBUTE TO HYPERURICEMIA IN PREMENOPAUNITED STATES OF AMERICAL FEMALE SYSTEMIC LUPUS ERYTHEMATOSUS PATIENTS

FRI0391 The relationship between oestrogen receptors and hyperuricemia in young female systemic lupus erythematosus patients

Renal tubular and glomerular estrogen receptor ß levels are lower in lupus nephritis than in familial Mediterranean fever-associated renal amyloidosis

Elevated uric acid levels in premenopausal female systemic lupus erythematosus patients: Association with potential or existing renal damage

Estrogen Receptor α Signaling Exacerbates Immune-Mediated Nephropathies through Alteration of Metabolic Activity

Low expression of estrogen receptor β in T lymphocytes and high serum levels of anti-estrogen receptor α antibodies impact disease activity in female patients with systemic lupus erythematosus

Relationship between the expression of estrogen receptor and bone mineral density in patients with initial systemic lupus erythematosus

Elevated serum cholesterol levels are associated with proteinuria over 0.5 g/day in premenopausal women with systemic lupus erythematosus

Increased Urinary Interleukin 22 Binding Protein Levels Correlate with Lupus Nephritis Activity

Prevalence and risk factors of hyperuricemia in patients with lupus nephritis

The change and clinical significance of the serum uric acid levels in patients with lupus nephritis

Estrogen receptor gene polymorphism and its association with clinicopathological manifestation of lupus nephritis

Serum Uric Acid Combined with Homocysteine as a Predictive Biomarker of Lupus Nephritis

Sex Differences in Estrogen Receptor Gene Polymorphism and Its Association with Lupus Nephritis in Chinese

Estrogen-induced expression of tumor necrosis factor-like weak inducer of apoptosis through ERα accelerates the progression of lupus nephritis

Elevated serum uric acid is associated with renal arteriolopathy and predict poor outcome in patients with lupus nephritis

Hyperuricemia is an Independent Risk Factor for Renal Pathological Damage and Poor Prognosis in Lupus Nephritis Patients

The Prevalence, Subtypes and Associated Factors of Hyperuricemia in Lupus Nephritis Patients at Chronic Kidney Disease Stages 1-3.

Characteristics and Renal Survival of Patients with Lupus Nephritis with Glomerular Immunoglobulin G4 Deposition: a Single-Centre Retrospective Analysis.

The relationship of vitamin D endocrine system and estrogen receptor expression with bone mineral density in initial systemic lupus erythematosus